AtaiBeckley (ATAI) Research & Development (2020 - 2026)
AtaiBeckley (ATAI) recorded quarterly Research & Development of $17.4 million in Q1 2026, up 53.73% quarter-over-quarter from $11.3 million in Q1 2025, and up 53.73% on a YoY basis from $11.3 million in Q1 2025.
AtaiBeckley (ATAI) Research & Development (2020 - 2026) Analysis & Trends
AtaiBeckley has disclosed Research & Development across 6 years of filings, most recently posting $14.7 million for Q3 2025.
- Research & Development for Q3 2025 came in at $14.7 million, up 18.61% year-over-year; the trailing twelve-month figure through Sep 2025 was $56.0 million (up 10.61% YoY), and the FY2024 annual result was $55.5 million, down 10.85% from the prior year.
- Research & Development was $17.4 million for Q1 2026 at AtaiBeckley, up from $11.3 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $17.4 million in Q1 2026 to a low of $11.3 million in Q1 2025.
- The 5-year median for Research & Development is $14.2 million (2023), against an average of $14.6 million.
- Across the five-year window, Research & Development jumped 461.53% in 2021 and sank 40.2% in 2024, its largest moves.
- AtaiBeckley's Research & Development stood at $13.0 million in 2021, then jumped by 68.51% to $21.9 million in 2022, then plunged by 35.29% to $14.2 million in 2023, then jumped by 33.81% to $18.9 million in 2024, then slipped by 22.5% to $14.7 million in 2025.
- The last three Research & Development figures came in at $14.7 million (Q3 2025), $11.1 million (Q2 2025), and $11.3 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | 17.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.41 Mn |
| Sep 30, 2025 | 14.68 Mn |
| Jun 30, 2025 | 11.09 Mn |
| Mar 31, 2025 | 11.33 Mn |
| Mar 31, 2025 | 11.33 Mn |
| Dec 31, 2024 | 18.94 Mn |
| Sep 30, 2024 | 12.38 Mn |
| Jun 30, 2024 | 12.61 Mn |
| Mar 31, 2024 | 11.53 Mn |
| Dec 31, 2023 | 14.16 Mn |
| Sep 30, 2023 | 13.29 Mn |
| Jun 30, 2023 | 15.48 Mn |
| Mar 31, 2023 | 19.28 Mn |
| Dec 31, 2022 | 21.88 Mn |
| Sep 30, 2022 | 19.03 Mn |
| Jun 30, 2022 | 17.95 Mn |
| Mar 31, 2022 | 15.46 Mn |
| Dec 31, 2021 | 12.98 Mn |
| Sep 30, 2021 | 13.36 Mn |
| Jun 30, 2021 | 16.03 Mn |